Medical evaluation of patients undergoing electroconvulsive therapy

New England Journal of Medicine

Volumn 360, Issue 14, 2009, Pages 1437-1444

  Tess, Anjala V ^a,b   Smetana, Gerald W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIANGINA PECTORIS AGENT; ANTIHYPERTENSIVE AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; CLOPIDOGREL; CORTICOSTEROID; DILTIAZEM; ESMOLOL; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUPROFEN; KETOROLAC; LABETALOL; LONG ACTING INSULIN; NICARDIPINE; NITROPRUSSIDE SODIUM; PARACETAMOL; SUMATRIPTAN;

ASYSTOLE; BRADYCARDIA; BRAIN DAMAGE; CLINICAL EVALUATION; CONSULTATION; DRUG RESPONSE; ELECTROCONVULSIVE THERAPY; HEADACHE; HEALTH CARE PERSONNEL; HEART DISEASE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; MAJOR DEPRESSION; MANIA; MENTAL DISEASE; MORBIDITY; PATIENT ASSESSMENT; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIFORM DISORDER; STROKE; TREATMENT INDICATION; VASCULAR LESION; AGE; BIPOLAR DISORDER; CARDIOVASCULAR DISEASE; MEMORY DISORDER; METHODOLOGY; PSYCHOSIS; RISK ASSESSMENT;

AGE FACTORS; BIPOLAR DISORDER; CARDIOVASCULAR DISEASES; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; HUMANS; MEMORY DISORDERS; PSYCHOTIC DISORDERS; RISK ASSESSMENT;

EID: 63849282626     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMra0707755     Document Type: Review

References (52)

1. Lisanby SH. Electroconvulsive therapy for depression. N Engl J Med 2007;357:1939-1945.
2. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging. 2nd ed. Washington, DC: American Psychiatric Association, 2001.
3. Kramer BA. Use of ECT in California, 1977-1983. Am J Psychiatry 1985;142:1190-1192
4. Shiwach RS, Reid WH, Carmody TJ. An analysis of reported deaths following electroconvulsive therapy in Texas, 1993-1998. Psychiatr Serv 2001;52:1095-1097
5. Burd J, Kettl P. Incidence of asystole in electroconvulsive therapy in elderly patients. Am J Geriatr Psychiatry 1998;6:203-211 (Pubitemid 28313203)
6. Weinger MB, Partridge BL, Hauger R, Mirow A. Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy. I. Effectiveness of pretreatment regimens on hemodynamics. Anesth Analg 1991;73:556-562
7. Takada JY, Solimene MC, da Luz PL, et al. Assessment of the cardiovascular effects of electroconvulsive therapy in individuals older than 50 years. Braz J Med Biol Res 2005;38:1349-1357
8. McCully RB, Karon BL, Rummans TA, et al. Frequency of left ventricular dysfunction after electroconvulsive therapy. Am J Cardiol 2003;91:1147-1150
9. Gerring JP, Shields HM. The identification and management of patients with a high risk for cardiac arrhythmias during modified ECT. J Clin Psychiatry 1982;43:140-143
10. Alexopoulos GS, Shamoian CJ, Lucas J, Weiser N, Berger H. Medical problems of geriatric psychiatric patients and younger controls during electroconvulsive therapy. J Am Geriatr Soc 1984;32:651-654 (Pubitemid 14003760)
11. Dec GW Jr, Stern TA, Welch C. The effects of electroconvulsive therapy on serial electrocardiograms and serum cardiac enzyme values: a prospective study of depressed hospitalized inpatients. JAMA 1985;253:2525-2529 (Pubitemid 15008019)
12. Zielinski RJ, Roose SP, Devanand DP, Woodring S, Sackeim HA. Cardiovascular complications of ECT in depressed patients with cardiac disease. Am J Psychiatry 1993;150:904-909 (Pubitemid 23156771)
13. Rice EH, Sombrotto LB, Markowitz JC, Leon AC. Cardiovascular morbidity in high-risk patients during ECT. Am J Psychiatry 1994;151:1637-1641 (Pubitemid 24337596)
14. Tecoult E, Nathan N. Morbidity in electroconvulsive therapy. Eur J Anaesthesiol 2001;18:511-518 (Pubitemid 32863115)
15. Rumi DO, Solimene MC, Takada JY, et al. Electrocardiographic and blood pressure alterations during electroconvulsive therapy in young adults. Arq Bras Cardiol 2002;79:149-160
16. Cattan RA, Barry PP, Mead G, Reefe WE, Gay A, Silverman M. Electroconvulsive therapy in octogenarians. J Am Geriatr Soc 1990;38:753-758 (Pubitemid 20225820)
17. The UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003;361:799-808. (Pubitemid 36331841)
18. Sackeim HA, Prudic J, Fuller R, Keilp J, Lavori PW, Olfson M. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology 2007;32:244-254
19. Rose D, Fleischmann P, Wykes T, Leese M, Bindman J. Patients' perspectives on electroconvulsive therapy: systematic review. BMJ 2003;326:1363. (Pubitemid 36751033)
20. Weiner SJ, Ward TN, Ravaris CL. Headache and electroconvulsive therapy. Headache 1994;34:155-159 (Pubitemid 24129307)
21. Devanand DP, Fitzsimons L, Prudic J, Sackeim HA. Subjective side effects during electroconvulsive therapy. Convuls Ther 1995;11:232-240 (Pubitemid 26002250)
22. de Carle AJ, Kohn R. Electroconvulsive therapy and falls in the elderly. J ECT 2000;16:252-257
23. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 2007;50:1707-1732
24. Patra KK, Coffey CE. Implications of herbal alternative medicine for electroconvulsive therapy. J ECT 2004;20:186-194 (Pubitemid 39281570)
25. Miller LJ. Use of electroconvulsive therapy during pregnancy. Hosp Community Psychiatry 1994;45:444-450 (Pubitemid 24129371)
26. Maltbie AA, Wingfield MS, Volow MR, Weiner RD, Sullivan JL, Cavenar JO Jr. Electroconvulsive therapy in the presence of brain tumor: case reports and an evaluation of risk. J Nerv Ment Dis 1980;168:400-405 (Pubitemid 10070149)
27. Rasmussen KG, Perry CL, Sutor B, Moore KM. ECT in patients with intracranial masses. J Neuropsychiatry Clin Neurosci 2007;19:191-193 (Pubitemid 46649644)
28. Patkar AA, Hill KP, Weinstein SP, Schwartz SL. ECT in the presence of brain tumor and increased intracranial pressure: evaluation and reduction of risk. J ECT 2000;16:189-197
29. Najjar F, Guttmacher LB. ECT in the presence of intracranial aneurysm. J ECT 1998;14:266-271 (Pubitemid 29003838)
30. Martin M, Figiel G, Mattingly G, Zorumski CF, Jarvis MR. ECT-induced interictal delirium in patients with a history of a CVA. J Geriatr Psychiatry Neurol 1992;5:149-155
31. Selim M. Perioperative stroke. N Engl J Med 2007;356:706-713 (Pubitemid 46257233)
32. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252 (Pubitemid 37553153)
33. Howie MB, Black HA, Zvara D, McSweeney TD, Martin DJ, Coffman JA. Esmolol reduces autonomic hypersensitivity and length of seizures induced by electroconvulsive therapy. Anesth Analg 1990;71:384-388
34. van den Broek WW, Leentjens AF, Mulder PG, Kusuma A, Bruijn JA. Low-dose esmolol bolus reduces seizure duration during electroconvulsive therapy: a double-blind, placebo-controlled study. Br J Anaesth 1999;83:271-274 (Pubitemid 29361139)
35. Howie MB, Hiestand DC, Zvara DA, Kim PY, McSweeney TD, Coffman JA. Defining the dose range for esmolol used in electroconvulsive therapy hemodynamic attenuation. Anesth Analg 1992;75:805-810
36. Mueller PS, Barnes RD, Varghese R, Nishimura R, Rasmussen KG. The safety of electroconvulsive therapy in patients with severe aortic stenosis. Mayo Clin Proc 2007;82:1360-1363 (Pubitemid 350060131)
37. Dolenc TJ, Barnes RD, Hayes DL, Rasmussen KG. Electroconvulsive therapy in patients with cardiac pacemakers and implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2004;27:1257-1263 (Pubitemid 39281922)
38. Petrides G, Fink M. Atrial fibrillation, anticoagulation, and electroconvulsive therapy. Convuls Ther 1996;12:91-98 (Pubitemid 26162465)
39. Mehta V, Mueller PS, Gonzalez-Arriaza HL, Pankratz VS, Rummans TA. Safety of electroconvulsive therapy in patients receiving long-term warfarin therapy. Mayo Clin Proc 2004;79:1396-1401 (Pubitemid 39453304)
40. Devanand DP, Decina P, Sackeim HA, Prudic J. Status epilepticus following ECT in a patient receiving theophylline. J Clin Psychopharmacol 1988;8:153.
41. Mueller PS, Schak KM, Barnes RD, Rasmussen KG. Safety of electroconvulsive therapy in patients with asthma. Neth J Med 2006;64:417-421 (Pubitemid 46001910)
42. Castelli I, Steiner LA, Kaufmann MA, et al. Comparative effects of esmolol and labetalol to attenuate hyperdynamic states after electroconvulsive therapy. Anesth Analg 1995;80:557-561
43. Dannon PN, Iancu I, Hirschmann S, Ross P, Dolberg OT, Grunhaus L. Labetalol does not lengthen asystole during electroconvulsive therapy. J ECT 1998;14:245-250 (Pubitemid 29003834)
44. Decina P, Malitz S, Sackeim HA, Holzer J, Yudofsky S. Cardiac arrest during ECT modified by beta-adrenergic blockade. Am J Psychiatry 1984;141:298-300. (Pubitemid 14180987)
45. McCall WV. Asystole in electroconvulsive therapy: report of four cases. J Clin Psychiatry 1996;57:199-203. (Pubitemid 26158854)
46. Mayur PM, Shree RS, Gangadhar BN, Subbakrishna DK, Janakiramaiah N, Rao GS. Atropine premedication and the cardiovascular response to electroconvulsive therapy. Br J Anaesth 1998;81:466-467 (Pubitemid 28416634)
47. Greenan J, Dewar M, Jones CJ. Intravenous glycopyrrolate and atropine at induction of anaesthesia: a comparison. J R Soc Med 1983;76:369-371
48. Rasmussen P, Andersson JE, Koch P, et al. Glycopyrrolate prevents extreme bradycardia and cerebral deoxygenation during electroconvulsive therapy. J ECT 2007;23:147-152
49. Wijeysundera DN, Naik JS, Beattie WS. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med 2003;114:742-752 (Pubitemid 36776356)
50. Locala JA, Irefin SA, Malone D, et al. The comparative hemodynamic effects of methohexital and remifentanil in electroconvulsive therapy. J ECT 2005;21:12-15
51. Markowitz JS, Kellner CH, DeVane CL, et al. Intranasal sumatriptan in post-ECT headache: results of an open-label trial. J ECT 2001;17:280-283
52. Leung M, Hollander Y, Brown GR. Pretreatment with ibuprofen to prevent electroconvulsive therapy-induced headache. J Clin Psychiatry 2003;64:551-553 (Pubitemid 36618284)